The Europe Probiotics Dietary Supplements Market is expected to witness market growth of 7.5% CAGR during the forecast period (2021-2027).
Probiotics can be considered as the living microbial food ingredients that offer many health advantages. In addition, these dietary supplements fall in the category of microorganisms, which can promote health by striking the ideal balance of bacteria in the intestines. Additionally, these ingredients act as catalysts for digestive juices and enzymes in the body and facilitate the appropriate functioning of the digestive system, and can be administered through food or in the form of supplements.
Europe has been a leading region in the overall probiotics dietary supplements market. Factors such as growing utilization of probiotics, high accessibility, and the existence of key market players are acting as growth catalysts for the regional probiotics dietary supplements market.
Additionally, probiotics are also helpful to gut microflora of human, which has fueled the adoption of probiotic dairy products like yogurt and yogurt drinks made by Yakult, Nestle, and Danone across the European region. In addition, the massive demand for functional foods in the countries like France, Spain, Germany, the UK, and Italy is expected to fuel the growth of the regional market. Hence, these factors is expected to play a major role in fuelling the growth of the regional market during the forecasting period.
The Germany market dominated the Europe Probiotics Dietary Supplements Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $672.3 million by 2027. The UK market is exhibit a CAGR of 6.4% during (2021 - 2027). Additionally, The France market is expected to showcase a CAGR of 8.8% during (2021 - 2027).
Based on Form, the Probiotics Dietary Supplements market is segmented into Capsules, Chewables & Gummies, Powders, Tablets & Softgels, and Others. Based on End User, the market is segmented into Adults, Geriatric, Children, and Infants. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., DuPont de Nemours, Inc., Chr. Hansen holding A/S, Archer Daniels Midland Company, Probi AB, BioGaia AB, Vitakem Nutraceutical, Inc., and ProbioFerm.
Scope of the Study
Market Segments Covered in the Report:
By Form
- Capsules
- Chewables & Gummies
- Powders
- Tablets & Softgels
- and Others
By End User
- Adults
- Geriatric
- Children
- Infants
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Methodology
LOADING...
